AstraZeneca Gets in on ADC Therapeutics' Mega $200M Funding Round Post author:Sam Post published:October 22, 2017 Post category:BioPharma ADC Therapeutics announced it had raised $200M through an oversubscribed private placement. Source: BioSpace You Might Also Like How This CRISPR Biotech Could Make Investors Rich December 26, 2017 Bay Area's XOMA Snags $240M Deal With Newly-Transformed Rezolute December 6, 2017 Aeterna Zentaris Forges $24M Tie-Up With Strongbridge January 16, 2018